Mylan To Launch Competing Generic Version Of Provigil

June 2012
Investors Business Daily;6/ 8/2012, p00
No abstract available.


Related Articles

  • MYLAN INC.  // MondayMorning;6/11/2012, Vol. 20 Issue 23, p1 

    The article informs that Mylan Inc. has claimed that it has it resolved disputes with Teva Pharmaceutical Industries Ltd. over the sale of U.S. generic versions of sleep-disorder drug Provigil. Mylan, the world's No. 3 generic drugmaker, had challenged rights of Teva, the world's largest generic...

  • Mylan downgraded.  // Dow Theory Forecasts;6/28/2004, Vol. 60 Issue 26, p1 

    Reports that shares of Mylan Laboratories tumbled following a court ruling that will post the launch of a generic version of the Duragesic pain-relief patch. Delay in Mylan's rollout of a generic Duragesic until early 2005; Decline in Mylan's Quadrix Overall score in 2004.

  • GENERICS NEWSLINE.  // MPR - Physician Assistants' Edition;Spring2015, Vol. 22 Issue 1, pA8 

    This section offers news briefs on generics medicine. These include the launch of Clobetasol Propionate Spray 0.05%, the generic version of Galderma's Clobex Spray by Perrigo, Teva's launch of Linezolid Injection, the generic version of Pfizer's Zyvox Injection and Mylan's launch of Estradiol...

  • Mylan launches generic sofosbuvir for treatment of hepatitis C.  // FRPT- Chemical Snapshot;5/10/2015, p14 

    The article announces the launch of the generic version of Hepatitis C drug sofosbuvir under the brand name MyHep by pharmaceutical company Mylan NV.

  • GENERICS NEWSLINE.  // MPR - Pharmacist's Edition;Summer2012, Vol. 6 Issue 2, pA.8 

    The article offers brief information on generic drugs. Teva Pharmaceuticals Srl has launched its Escitalopram tablets which is the generic version of Forest Laboratories Inc.'s Lexapro. Watson Pharmaceuticals Inc. has unveiled its Metformin hydrochloride extended-release tablets which is the...

  • BUZZ'NBYTES.  // Drug Store News;Feb2016, Vol. 38 Issue 2, p30 

    The article offers information related on the pharmaceutical industry and the pharmacy sector in the U.S. for 2016. It mentions the launch of a generic version of Felbatol tablets by Mylan aimed for the treatment of partial seizure. It cites the approval of the generic version of Aygestin from...

  • Pharma: Other News To Note.  // BioWorld Today;4/2/2012, Vol. 23 Issue 63, p8 

    This section offers news briefs on the biopharmaceutical sector including the research collaboration deal between HTG Molecular Diagnostics and Sanofi US, a plan by Shire PLC to conduct additional trials of midodrine hydrochloride, and the launch by Teva Pharmaceutical Industires Ltd. of a...

  • FTC reaches settlement with Teva in pay-for-delay case.  // Chain Drug Review;6/15/2015, Vol. 37 Issue 10, p11 

    The article reports that the U.S. Federal Trade Commission has reached settlement with pharmaceutical firm Teva Pharmaceutical Industries Ltd. to settle a lawsuit which alleged that its subsidiary has illegally blocked the launch of generic versions of its Provigil sleeping pill.

  • CNS News Round-Up.  // PharmaWatch: CNS;Jul2011, Vol. 10 Issue 7, p2 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the launches of the new generic version of pain and schizophrenic drugs from Mylan Pharmaceuticals Inc. and the approval issued to Teva Pharmaceutical Industries Ltd.

  • US tonic for Natco.  // Telegraph (Calcutta, India);6/20/2015, p11 

    The article reports on the plan of Hyderabad, India-based pharmaceutical companies Natco Pharma Ltd. with Mylan NV to launch a generic version of Copaxone in the U.S. market in 2015.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics